Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Diabetes

Understanding diabetes

Diabetes is a condition in the body where blood sugar levels are higher than normal. This can happen when the body either doesn’t make any insulin (type 1 diabetes), or the insulin that the body makes doesn’t work well (type 2 diabetes).

Mother with small medical device on arm

Type 1 diabetes

Type 1 diabetes occurs when a person’s body either makes too little or doesn’t make any insulin. When insulin is not available in the body, glucose cannot enter the body’s cells to give the body energy.

Type 1 diabetes can develop in childhood or adulthood. The condition can be triggered by environmental factors, a virus, or another unknown trigger.

Type 2 diabetes

Type 2 diabetes is often referred to as “adult onset” diabetes. With type 2 diabetes, the pancreas can still make some insulin, but either it doesn’t make enough, or the body’s cells don’t respond to it as effectively as they used to. When the cells don’t respond as effectively, this is called “insulin resistance.” This means glucose is not getting into the cells where it’s needed to function properly.

Two women walking, wearing insulin pump

Arm indication approved for ages 14 and older.

Type 2 diabetes

Type 2 diabetes is often referred to as “adult onset” diabetes. With type 2 diabetes, the pancreas can still make some insulin, but either it doesn’t make enough, or the body’s cells don’t respond to it as effectively as they used to. When the cells don’t respond as effectively, this is called “insulin resistance.” This means glucose is not getting into the cells where it’s needed to function properly.


Important Safety Information: MiniMed 630G System with SmartGuard Technology
Indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus. MiniMed 630G system is approved for ages 14 years or older with Guardian Sensor 3 and MiniMed 630G system is approved for ages 16 years or older with Enlite sensor. Both systems require a prescription. Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately. Replace the infusion set every 48–72 hours, or more frequently per your healthcare professional’s instructions. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter. A confirmatory fingerstick using a CONTOUR® NEXT LINK 2.4 meter is required prior to making adjustments to diabetes therapy. Always check the pump display when using a CONTOUR® NEXT LINK 2.4 meter, to ensure the glucose result shown agrees with the glucose results shown on the meter. Do not calibrate your CGM device or calculate a bolus using a result taken from an Alternative Site (palm) or a result from a control solution test. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. The MiniMed 630G system is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Suspend on low alarm and take measures to prevent or treat hypoglycemia themselves. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare provider.

WARNING: The SmartGuard Suspend on low feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again, resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the SmartGuard feature, it is important to read the SmartGuard feature information in the User Guide and discuss proper use of the feature with your healthcare provider.

Important Safety Information: Guardian Connect CGM System
The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.